Daniel Wilson

Portrait
Daniel Wilson, Executive Vice President, Corporate Development and Investor Relations

Daniel Wilson has served as our Executive Vice President, Corporate Development and Investor Relations since April 2023 and previously served as Executive Vice President, Corporate Development, Corporate Strategy and Investor Relations since June 2019 to April 2023. Previously, he served as Director and Head of Business Development at Penumbra, Inc., a global healthcare company focused on innovative therapies. Prior to Penumbra, he held various positions at J.P. Morgan between August 2006 and May 2016, most recently as Executive Director in the Healthcare Investment Banking group focused on digital health, medical technology and emerging healthcare companies. Earlier in his career, he held various positions in Piper Jaffray’s Healthcare Investment Banking group from August 2004 to August 2006. He started his career at KPMG as an Audit Associate from September 2003 to August 2004.

Mr. Wilson has a B.S. in Business Administration from California Polytechnic State University at San Luis Obispo.

Email Alerts

Sign up to receive e-mail alerts whenever iRhythm posts new information to the site.